First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma ; volume:16 ; number:1 ; day:29 ; month:5 ; year:2018 ; pages:1-9 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (29.5.2018), 1-9, 12.2018

Creator: Liau, Linda M.

Contributor: Ashkan, Keyoumars
Tran, David D.
Campian, Jian L.
Trusheim, John E.
Cobbs, Charles S.
Heth, Jason A.
Salacz, Michael
Taylor, Sarah
D’Andre, Stacy D.
Iwamoto, Fabio M.
Dropcho, Edward J.
Moshel, Yaron A.
Walter, Kevin A.
Pillainayagam, Clement P.
Aiken, Robert
Chaudhary, Rekha
Goldlust, Samuel A.
Bota, Daniela A.
Duic, Paul
Grewal, Jai
Elinzano, Heinrich
Toms, Steven A.
Lillehei, Kevin O.
Mikkelsen, Tom
Walbert, Tobias
Abram, Steven R.
Brenner, Andrew J.
Brem, Steven
Ewend, Matthew G.
Khagi, Simon
Portnow, Jana
Kim, Lyndon J.
Loudon, William G.
Thompson, Reid C.
Avigan, David E.
Fink, Karen L.
Geoffroy, Francois J.
Lindhorst, Scott
Lutzky, Jose
Sloan, Andrew E.
Schackert, Gabriele
Krex, Dietmar
Meisel, Hans-Jorg
Wu, Julian
Davis, Raphael P.
Duma, Christopher
Etame, Arnold B.
Mathieu, David
Kesari, Santosh
Piccioni, David
Westphal, Manfred
Baskin, David S.
New, Pamela Z.
Lacroix, Michel
May, Sven-Axel
Pluard, Timothy J.
Tse, Victor
Green, Richard M.
Villano, John L.
Pearlman, Michael
Petrecca, Kevin
Schulder, Michael
Taylor, Lynne P.
Maida, Anthony E.
Prins, Robert M.
Cloughesy, Timothy F.
Mulholland, Paul
Bosch, Marnix L.
SpringerLink (Online service)

DOI: 10.1186/s12967-018-1507-6

URN: urn:nbn:de:101:1-2018091202085872085645

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:40 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liau, Linda M.
Ashkan, Keyoumars
Tran, David D.
Campian, Jian L.
Trusheim, John E.
Cobbs, Charles S.
Heth, Jason A.
Salacz, Michael
Taylor, Sarah
D’Andre, Stacy D.
Iwamoto, Fabio M.
Dropcho, Edward J.
Moshel, Yaron A.
Walter, Kevin A.
Pillainayagam, Clement P.
Aiken, Robert
Chaudhary, Rekha
Goldlust, Samuel A.
Bota, Daniela A.
Duic, Paul
Grewal, Jai
Elinzano, Heinrich
Toms, Steven A.
Lillehei, Kevin O.
Mikkelsen, Tom
Walbert, Tobias
Abram, Steven R.
Brenner, Andrew J.
Brem, Steven
Ewend, Matthew G.
Khagi, Simon
Portnow, Jana
Kim, Lyndon J.
Loudon, William G.
Thompson, Reid C.
Avigan, David E.
Fink, Karen L.
Geoffroy, Francois J.
Lindhorst, Scott
Lutzky, Jose
Sloan, Andrew E.
Schackert, Gabriele
Krex, Dietmar
Meisel, Hans-Jorg
Wu, Julian
Davis, Raphael P.
Duma, Christopher
Etame, Arnold B.
Mathieu, David
Kesari, Santosh
Piccioni, David
Westphal, Manfred
Baskin, David S.
New, Pamela Z.
Lacroix, Michel
May, Sven-Axel
Pluard, Timothy J.
Tse, Victor
Green, Richard M.
Villano, John L.
Pearlman, Michael
Petrecca, Kevin
Schulder, Michael
Taylor, Lynne P.
Maida, Anthony E.
Prins, Robert M.
Cloughesy, Timothy F.
Mulholland, Paul
Bosch, Marnix L.
SpringerLink (Online service)

Other Objects (12)

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Related objects

Reset password